Literature DB >> 17441958

Fibroblast growth factor receptor 3 (FGFR3) mutation in a verrucous epidermal naevus associated with mild facial dysmorphism.

B Collin1, I B Taylor, A O M Wilkie, C Moss.   

Abstract

We report an activating fibroblast growth factor receptor 3 (FGFR3) mutation (R248C) occurring in a verrucous epidermal naevus, and not found in other tissues, in a girl with mild facial dysmorphism. We demonstrate the presence of the mutation in keratinocytes cultured from the naevus and we speculate that a low level of the mutation in other tissues may account for her facial dysmorphism. The possibility that the mutation is present in other tissues implies a possible risk to her future offspring.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17441958     DOI: 10.1111/j.1365-2133.2007.07869.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Systemic epidermal nevus with involvement of the oral mucosa due to FGFR3 mutation.

Authors:  Anette Bygum; Christina R Fagerberg; Ole J Clemmensen; Britta Fiebig; Christian Hafner
Journal:  BMC Med Genet       Date:  2011-06-05       Impact factor: 2.103

Review 2.  [Genetic basis of seborrheic keratosis and epidermal nevi].

Authors:  C Hafner; H Hafner; L Groesser
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 3.  Mosaic RASopathies.

Authors:  Christian Hafner; Leopold Groesser
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

4.  Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation.

Authors:  Said Farschtschi; Victor-Felix Mautner; Silke Hollants; Christian Hagel; Marijke Spaepen; Christoph Schulte; Eric Legius; Hilde Brems
Journal:  BMC Med Genet       Date:  2015-02-10       Impact factor: 2.103

5.  Late onset epidermal nevus with hypertrichosis and facial hemihypertrophy.

Authors:  M Saritha; Laxmisha Chandrashekar; Devinder Mohan Thappa; A Ramesh; Debdatta Basu
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.